Skip to main content
Regina Rosenthal
( out of 149 reviews )

Regina Rosenthal, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
801-213-4269
  • Dr. Regina Rosenthal is a board-certified general surgeon practicing breast surgery at the University of Utah’s Huntsman Cancer Institute. She has more than twenty years of experience in the surgical treatment of breast cancer. She has been an early advocate for the multidisciplinary approach to breast cancer, which helps tailor treatment plans to the goals and needs of individuals.

    She earned her B.S. degree in biochemistry from The City College of New York and her M.D. from Albert Einstein College of Medicine of Yeshiva University, also in New York. She completed a residency in General Surgery at Boston University Medical Center in Boston, with an additional fellowship year in oncology research. She is board-certified in General Surgery by the American College of Surgeons and is a member of the American Society of Breast Surgeons.

    Dr. Rosenthal has practiced in Salt Lake City since 1991. She practiced all aspects of General Surgery, including trauma and abdominal surgery, until around 2002, when she began to focus her practice on breast cancer. Her practice has been directed exclusively to treating breast cancer and benign breast disease since that time. She is recognized as an early proponent of the team approach to breast cancer care in Salt Lake City.

    Dr. Rosenthal is able to offer a variety of surgical options depending on individual needs, including sentinel lymph node sampling, skin and nipple-sparing mastectomies, and the use of oncoplastic techniques to improve cosmetic results. She is prepared to incorporate reconstructive surgery approaches together with plastic surgeons as part of overall treatment plans. For many patients, more focused rather than more extensive surgery may be a good option. Cooperative presurgical planning with oncology and radiation oncology professionals can expand the range of choices available to individuals with breast cancer.

    Board Certification

    American Board of Surgery

    Patient Rating

    4.9 /5
    ( out of 149 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 13, 2023
    SUGAR HOUSE HEALTH CENTER

    Very nice and tried to make sure you got understood what was going on

    August 06, 2023
    SUGAR HOUSE HEALTH CENTER

    Regina Rosenthal MD is an exceptional physician, caregiver, and communicator. She inspires trust and confidence which gave me a positive attitude towards treatment.

    May 31, 2023
    HUNTSMAN CANCER CENTER

    I didnt mind waiting because I knew I could count on getting the same uninterrupted and complete attention she was probably giving the patient before me

    May 31, 2023
    HUNTSMAN CANCER CENTER

    She is a good dr and she knows her stuff. Very nice person.

    May 25, 2023
    HUNTSMAN CANCER CENTER

    I waited in the exam room for a long time to be seen by Dr. Rosenthal but once it happened, I was very impressed with her and the amount of time she spent talking to me, explaining things in detail and including me in decisions. She instilled confidence in the care I will be receiving.

    May 22, 2023
    SUGAR HOUSE HEALTH CENTER

    I trust Dr Rosenthal and feel like I'm in good hands under her care.

    May 19, 2023
    HUNTSMAN CANCER CENTER

    I felt seen, cared for and as though I mattered. Dr Rosenthal is the best Ive ever met. She was honest and open. I know together she & I will get me through this.

    May 12, 2023
    SUGAR HOUSE HEALTH CENTER

    She was very calm and patient with. Us. She cared about us

    May 09, 2023
    HUNTSMAN CANCER CENTER

    I explained to Dr Rosenthal some things that my Oncologist and I had discussed and since a few weeks had gone by, I had a few questions. Dr. Rosenthal listened to my questions and explained things in a way I could understand.

  • Dr. Regina Rosenthal is a board-certified general surgeon practicing breast surgery at the University of Utah’s Huntsman Cancer Institute. She has more than twenty years of experience in the surgical treatment of breast cancer. She has been an early advocate for the multidisciplinary approach to breast cancer, which helps tailor treatment plans to the goals and needs of individuals.

    She earned her B.S. degree in biochemistry from The City College of New York and her M.D. from Albert Einstein College of Medicine of Yeshiva University, also in New York. She completed a residency in General Surgery at Boston University Medical Center in Boston, with an additional fellowship year in oncology research. She is board-certified in General Surgery by the American College of Surgeons and is a member of the American Society of Breast Surgeons.

    Dr. Rosenthal has practiced in Salt Lake City since 1991. She practiced all aspects of General Surgery, including trauma and abdominal surgery, until around 2002, when she began to focus her practice on breast cancer. Her practice has been directed exclusively to treating breast cancer and benign breast disease since that time. She is recognized as an early proponent of the team approach to breast cancer care in Salt Lake City.

    Dr. Rosenthal is able to offer a variety of surgical options depending on individual needs, including sentinel lymph node sampling, skin and nipple-sparing mastectomies, and the use of oncoplastic techniques to improve cosmetic results. She is prepared to incorporate reconstructive surgery approaches together with plastic surgeons as part of overall treatment plans. For many patients, more focused rather than more extensive surgery may be a good option. Cooperative presurgical planning with oncology and radiation oncology professionals can expand the range of choices available to individuals with breast cancer.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions General Surgery
    Board Certification
    American Board of Surgery

    Education history

    Research Fellow Oncology - Boston University Medical Center Research Fellow
    Boston University Administrative Chief Resident
    Residency Boston University Resident
    Boston University Intern
    Professional Medical Medicine - Albert Einstein College of Medicine M.D.
    Biochemistry - City College of New York B.S.

    Selected Publications

    Journal Article

    1. Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. (Read full article)
    2. Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137.

    Case Report

    1. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. (Read full article)